Trexquant Investment LP Gossamer Bio, Inc. Transaction History

Trexquant Investment LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$5.97 - $9.97 $51,837 - $86,569	-8,683 Reduced 29.88%	20,378 $171,000
Q1 2022 May 13, 2022	BUY	$8.44 - $12.49 $119,527 - $176,883	14,162 Added 95.05%	29,061 $252,000
Q4 2021 Feb 14, 2022	SELL	$10.12 - $14.07 $39,872 - $55,435	-3,940 Reduced 20.91%	14,899 $169,000
Q3 2021 Nov 12, 2021	BUY	$7.25 - $13.23 $136,582 - $249,239	18,839 New	18,839 $237,000
Q1 2021 May 13, 2021	SELL	$8.63 - $10.94 $142,869 - $181,111	-16,555 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$8.3 - $13.59 $36,354 - $59,524	-4,380 Reduced 20.92%	16,555 $160,000
Q3 2020 Nov 06, 2020	BUY	$11.3 - $14.75 $236,565 - $308,791	20,935 New	20,935 $260,000
Q2 2020 Aug 07, 2020	SELL	$9.52 - $15.98 $128,443 - $215,602	-13,492 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$8.0 - $15.48 $107,936 - $208,856	13,492 New	13,492 $137,000

109

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $84.6M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.